Been hearing this a lot if a peptide is under $100, it’s probably underdosed or low purity. Talking mainly about stuff like BPC-157. You guys think price is a good indicator or just marketing? I’ve seen cheaper options but always wonder if it’s just a gamble at that point.

Statins given based on risk calculators, not hormones.

Hormone optimization considered specialized, not primary care routine.

Insurance coverage often limits comprehensive hormone testing panels.

Time constraints push doctors toward fast pharmaceutical solutions.

Evidence base stronger for SSRIs, statins than hormones.

Endocrine causes sometimes overlooked in general practice settings.

Patients rarely request full hormonal workups initially themselves.

Guidelines emphasize population outcomes over individualized hormone optimization.

Statins reduce cardiovascular risk regardless underlying hormone status.

SSRIs target neurotransmitters, not root hormonal imbalances directly.

Hormone therapy carries risks, requiring closer monitoring protocols.

Doctors cautious due to liability around hormone treatments.

Some symptoms overlap between hormonal and psychiatric conditions

Fixing hormones may help, but not always sufficient.

Medical systems prioritize standardized care over personalized optimization